| Name | Title | Contact Details |
|---|
Kolltan Pharmaceuticals is a private company founded in 2007 that is developing novel monoclonal antibody (mAb) drugs targeting receptor tyrosine kinases (RTKs). Kolltan's primary targets derive from seminal discoveries made in the laboratory of Dr. Joseph Schlessinger, Chairman of the Department of Pharmacology at the Yale School of Medicine, and in Kolltan’s laboratories. Dr. Schlessinger's laboratory has characterized a novel molecular mechanism underlying activation of RTKs providing, for the first time, a clear molecular explanation — at atomic resolution — for the oncogenic activity of mutations that have been identified in a variety of human cancers.
Schnepp Health Care Center is deeply committed to providing the highest quality rehabilitation services. Our facility offers a full-time physical therapist with full-time assistants and specially trained restorative nursing staff that continues to work
Wellstart International Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Wesleyan Nursing Home is a Georgetown, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Barton HealthCare System provides a variety of excellent medical services for patients, employees, visitors and the community.